Search results
15 sie 2024 · The imposed MFP for a 30-day equivalent supply of ELIQUIS, which is the price that Medicare will pay for ELIQUIS as of January 1, 2026, is $231.00.
29 sie 2023 · For patients receiving ELIQUIS doses of 5 mg or 10 mg twice daily, reduce the dose of ELIQUIS by 50% when ELIQUIS is coadministered with drugs that are combined P-gp and strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole, or ritonavir).
21 paź 2024 · We created an algorithm to help clinicians identify appropriate strategies based on a patient’s health insurance and the type of drug (brand-name vs generic). For example, co-payment cards can lower out-of-pocket costs for privately insured patients taking brand-name prescription drugs.
31 sty 2024 · Generic apixaban has been recommended by NHS England over the previous first choice, edoxaban (Lixiana; Daiichi Sankyo), as a preferred direct-acting oral anticoagulant (DOAC) for the treatment of atrial fibrillation (AF) in new patients.
The U.S. Food and Drug Administration has approved two applications for the first generics of Eliquis (apixaban) tablets to reduce the risk of stroke and systemic embolism in patients with...
By 2030, up to 80 drugs will have lower negotiated prices. One of the first ten drugs selected for negotiation is Eliquis, a drug used to treat blood clots, manufactured by Bristol Myers Squibb and Pfizer.
15 sie 2024 · Eliquis, a blood thinner from Bristol Myers Squibb and Pfizer: $231 negotiated price, down from $521 list price.
